title: Interleukin-2-associated bullous drug dermatosis.
authors.forename: M
authors.initials: M
authors.lastname: Hofmann
authors.forename: H
authors.initials: H
authors.lastname: Audring
authors.forename: W
authors.initials: W
authors.lastname: Sterry
authors.forename: U
authors.initials: U
authors.lastname: Trefzer
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000556:secondary; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000556:secondary
chemical_list: D000970:Antineoplastic Agents; D007376:Interleukin-2